Literature DB >> 27620993

Surgical oncology outcomes in the aging US population.

Heather L Yeo1, Paul R A O'Mahoney2, Mark Lachs3, Fabrizio Michelassi2, Jialin Mao4, Emily Finlayson5, Jonathan S Abelson2, Art Sedrakyan4.   

Abstract

BACKGROUND: As the population ages, an increasing number of older patients are undergoing major surgery. We examined the impact of advanced age on outcomes following major gastrointestinal cancer surgery in an era of improved surgical outcomes.
MATERIALS AND METHODS: This was a population-based, retrospective cohort study using the American College of Surgeons National Surgical Quality Improvement Program database. We evaluated patients undergoing major abdominal gastrointestinal cancer surgery from 2005-2012. Multivariable logistic regression was performed to determine the independent effect of advanced age on outcomes. Our primary outcome was 30-d mortality, and our secondary outcomes were 30-d major postoperative adverse events, discharge disposition, length of stay, reoperation, and readmission.
RESULTS: Elderly (≥65 y) patients were twice as likely to have multiple comorbidities as those <65 y but prevalence of comorbidities was similar across all older age groups. Mortality increased with age across all procedures (P < 0.05). The risk of advanced age on mortality was highest in hepatectomy (odds ratio = 5.17, 95% confidence interval = 2.19-12.20) and that for major postoperative adverse events was highest in proctectomy (odds ratio = 2.32, 95% confidence interval = 1.53-3.52). Patients were more likely to be discharged to an institutional care facility as age increased across all procedures (P < 0.01).
CONCLUSIONS: Despite being highly selected for surgery, elderly patients undergoing major gastrointestinal cancer surgery have substantially worse postoperative outcomes than younger patients (<65 y). The risk of age on postoperative outcomes was present across all operations but had its highest association with liver and rectal cancer resections.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  80 and over; Aged; Gastrointestinal neoplasms; Operative; Postoperative complications; Surgical procedures

Mesh:

Year:  2016        PMID: 27620993     DOI: 10.1016/j.jss.2016.04.038

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Severe Preoperative Symptoms Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection.

Authors:  Heather A Lillemoe; Rebecca K Marcus; Bradford J Kim; Nisha Narula; Catherine H Davis; Qiuling Shi; Xin Shelley Wang; Thomas A Aloia
Journal:  Ann Surg Oncol       Date:  2019-08-14       Impact factor: 5.344

Review 2.  Treatment of Rectal Cancer in Older Adults.

Authors:  Ayesha R Sheikh; Hassan Yameen; Kevan Hartshorn
Journal:  Curr Oncol Rep       Date:  2018-11-20       Impact factor: 5.075

3.  Early Hospital Readmission in Older and Younger Kidney Transplant Recipients.

Authors:  Christine E Haugen; Elizabeth A King; Sunjae Bae; Mary Grace Bowring; Courtenay M Holscher; Jacqueline Garonzik-Wang; Mara McAdams-DeMarco; Dorry L Segev
Journal:  Am J Nephrol       Date:  2018-09-18       Impact factor: 3.754

4.  Utilising advance care planning videos to empower perioperative cancer patients and families: a study protocol of a randomised controlled trial.

Authors:  Rebecca A Aslakson; Sarina R Isenberg; Norah L Crossnohere; Alison M Conca-Cheng; Ting Yang; Matthew Weiss; Angelo E Volandes; John F P Bridges; Debra L Roter
Journal:  BMJ Open       Date:  2017-06-06       Impact factor: 2.692

5.  Economic burden of cancer among patients with surgical resections of the lung, rectum, liver and uterus: results from a US hospital database claims analysis.

Authors:  Iftekhar Kalsekar; Chia-Wen Hsiao; Hang Cheng; Sashi Yadalam; Brian Po-Han Chen; Laura Goldstein; Andrew Yoo
Journal:  Health Econ Rev       Date:  2017-06-02

6.  Outcomes of colorectal cancer surgery in the nonagenarians: 20-year result from a tertiary center.

Authors:  Toi Yin Chan; Chi Chung Foo; Wai Lun Law; Oswens Lo
Journal:  BMC Surg       Date:  2019-10-28       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.